Simulect (basiliximab) - Novartis
Nulojix (belatacept) - BMS
Late Recurrence of Renal Cell Cancer After Kidney Transplantation (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO1207; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Induction was with steroids and Simulect, patient had DGF , started on monthly Belatacept infusions due to suboptimal Cr. Although tumor relapse can occur, most relapses occur within the first 5 years after nephrectomy. However, the modality and length of surveillance is not clear at this time." 
Chronic Kidney Disease • Gastrointestinal Disorder • Genito-urinary Cancer • Hypertension • Kidney Cancer • Musculoskeletal Diseases • Musculoskeletal Pain • Neuroendocrine Tumor • Oncology • Prostate Cancer • Renal Cell Carcinoma • Renal Disease • Solid Tumor • Transplantation
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4557385
 
Muhammad Raza Mustafa; Nandita Singh; Daniel G. Glicklich
 
Oct 2, 2026
 
Prev Next